Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Articles, guides, and regulatory updates from our community.
New rat study suggests BPC 157 may reduce oxidative stress and tissue damage from ischemia-reperfusion injury. Learn what the research shows and its limitations.
By Peptide Association Research Team
A 2026 review in Pharmaceutics examines BPC-157's biopharmaceutical challenges, pharmacokinetic gaps, and the barriers standing between preclinical promise and human trials.
By Peptide Association Research Team
A 2026 rat study found BPC 157 may reduce oxidative stress and apoptosis in lower limb ischemia-reperfusion injury. Learn what the research suggests.
By Peptide Association Research Team
A 2026 review in Pharmaceutics examines why BPC-157 lacks approved formulations, validated dosing, and completed Phase II trials despite 30+ years of preclinical data.
By Peptide Association Research Team
A 2026 rat study suggests BPC 157 may protect against ischemia-reperfusion injury by reducing oxidative stress, inflammation, and cell death. Learn what the research shows.
By Peptide Association Research Team
New research explores how mitochondria-targeted peptide nanoparticles may protect the liver from ischemia-reperfusion injury. Learn what the science shows.
By Peptide Association Research Team
A 2026 review in JBJS Reviews examines the evidence, safety, and antidoping implications of injectable peptides used in sports medicine and orthopaedics.
By Peptide Association Research Team
A 2026 ACS Nano study suggests mitochondria-targeted nanoparticles may reduce liver ischemia-reperfusion injury by limiting ROS and inflammation in mice.
By Peptide Association Research Team
A 2026 structured review examines injectable peptides for musculoskeletal recovery. Learn what the evidence, safety data, and antidoping rules mean for athletes.
By Peptide Association Research Team
New research explores how mitochondria-targeted polydopamine nanoparticles modified with SS-31 peptide may protect the liver from ischemia-reperfusion injury.
By Peptide Association Research Team
New research across 85 trials finds incretin-based therapies modestly reduce blood pressure and lower mortality in adults with obesity. Read the evidence.
By Peptide Association Research Team
New research explores retatrutide's role in CKM syndrome, showing significant weight loss, glycemic control, and cardiorenal benefits in Phase 2 trials.
By Peptide Association Research Team
New research reframes how the MASCC Risk Index predicts febrile neutropenia complications using likelihood ratios and Bayesian probability for better bedside decisions.
By Peptide Association Research Team
New research on retatrutide shows promising weight loss and metabolic results. Learn what the 2026 clinical review found about this triple hormone receptor agonist.
By Peptide Association Research Team
A 2026 review study examines nanocarriers, host-directed therapies, and antimicrobial peptides as next-generation tuberculosis treatment strategies.
By Peptide Association Research Team
A 2026 study validated a new insulin safety protocol, boosting healthcare professionals' knowledge from 32% to 70%. Learn what the research means for patient care.
By Peptide Association Research Team
New research explores how mitochondrial dysfunction affects female fertility and which therapeutic strategies may help restore ovarian function. Learn what the science says.
By Peptide Association Research Team
A 2026 study in Biogerontology suggests GHK-Cu may delay aging by supporting mitochondrial function and activating key longevity pathways. Learn what the research shows.
By Peptide Association Research Team
A 2026 study found BPC 157 may relax human arterial tissue via nitric oxide pathways. Learn what the research suggests and what patients should know.
By Peptide Association Research Team
A 2026 study suggests BPC 157 may relax human arterial tissue via nitric oxide signaling. Learn what the research found and what it means for vascular health.
By Peptide Association Research Team
A 2026 review study explores nanocarriers, host-directed therapies, and antimicrobial peptides as next-generation tuberculosis treatments. Learn what the research shows.
By Peptide Association Research Team
A 2026 study found BPC 157 may promote vasorelaxation in human arterial tissue via nitric oxide pathways. Learn what the research suggests.
By Peptide Association Research Team
New research explores nanocarriers, antimicrobial peptides, and host-directed strategies as next-generation tuberculosis treatments. Learn what the science says.
By Peptide Association Research Team
New research suggests IL-15 combined with Thymosin α1 may reverse immune cell aging in hepatocellular carcinoma. Learn what the study found and why it matters.
By Peptide Association Research Team